Clinical Trial Update: A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ALN-5288 in patients with Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ALN-5288

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: RECRUITING